Oct. 20 at 6:10 PM
$COEP Coeptis Shows How Biotech Can Fund Itself While Innovating. COEP is pioneering a dual-track model designed to sustain innovation while reducing reliance on dilutive funding. Coeptis’ cash position increased to
$1.X,996,726 June 30, 2025, reflecting revenue growth. COEP stock is favored by top institutions